Fidaxomicin: A Novel Agent for the Treatment of Clostridium difficile Infection
BACKGROUND: Due to the limitations of existing treatment options for Clostridium difficile infection (CDI), new therapies are needed.
Saved in:
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2015-01-01
|
Series: | Canadian Journal of Infectious Diseases and Medical Microbiology |
Online Access: | http://dx.doi.org/10.1155/2015/934594 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|